NeuPath Health Inc. (TSXV:NPTH)
Canada · Delayed Price · Currency is CAD 0.5200
+0.0100 (1.96%)
At close: Dec 19, 2025
NeuPath Health Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Operating Revenue | 83.93 | 72.81 | 66.1 | 62.65 | 60.86 | 47.64 | Upgrade |
| 83.93 | 72.81 | 66.1 | 62.65 | 60.86 | 47.64 | Upgrade | |
Revenue Growth (YoY) | 18.67% | 10.14% | 5.50% | 2.95% | 27.74% | -4.03% | Upgrade |
Cost of Revenue | 67.78 | 58.95 | 53.81 | 51.83 | 49.8 | 37.92 | Upgrade |
Gross Profit | 16.16 | 13.86 | 12.3 | 10.82 | 11.06 | 9.72 | Upgrade |
Selling, General & Admin | 11.52 | 10.15 | 9.25 | 9.41 | 9.95 | 8.04 | Upgrade |
Operating Expenses | 13.84 | 12.45 | 11.86 | 12.08 | 12.97 | 10.54 | Upgrade |
Operating Income | 2.32 | 1.41 | 0.44 | -1.26 | -1.91 | -0.82 | Upgrade |
Interest Expense | -0.92 | -0.95 | -0.93 | -0.83 | -0.88 | -1.47 | Upgrade |
Interest & Investment Income | - | - | 0.01 | 0.02 | 0.03 | 0.05 | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | - | - | -0.56 | Upgrade |
EBT Excluding Unusual Items | 1.4 | 0.46 | -0.48 | -2.07 | -2.76 | -2.81 | Upgrade |
Merger & Restructuring Charges | -1.21 | -0.72 | -0.23 | -0.58 | -0.56 | - | Upgrade |
Gain (Loss) on Sale of Assets | -0.02 | -0.02 | 0.76 | - | - | - | Upgrade |
Asset Writedown | - | - | - | -1.94 | - | - | Upgrade |
Other Unusual Items | - | - | - | 0.5 | 0.07 | -2.05 | Upgrade |
Pretax Income | 0.18 | -0.27 | 0.06 | -4.08 | -3.25 | -4.86 | Upgrade |
Income Tax Expense | 0.44 | 0.21 | 0.25 | 0.19 | -0.02 | 0.2 | Upgrade |
Earnings From Continuing Operations | -0.26 | -0.49 | -0.19 | -4.28 | -3.23 | -5.06 | Upgrade |
Minority Interest in Earnings | -0.29 | -0.24 | 0.08 | 0.13 | - | - | Upgrade |
Net Income | -0.55 | -0.73 | -0.11 | -4.14 | -3.23 | -5.06 | Upgrade |
Net Income to Common | -0.55 | -0.73 | -0.11 | -4.14 | -3.23 | -5.06 | Upgrade |
Shares Outstanding (Basic) | 56 | 56 | 55 | 48 | 45 | 24 | Upgrade |
Shares Outstanding (Diluted) | 56 | 57 | 55 | 48 | 45 | 24 | Upgrade |
Shares Change (YoY) | 0.15% | 3.54% | 14.44% | 7.40% | 84.24% | 56.61% | Upgrade |
EPS (Basic) | -0.01 | -0.01 | -0.00 | -0.09 | -0.07 | -0.21 | Upgrade |
EPS (Diluted) | -0.01 | -0.01 | -0.00 | -0.09 | -0.07 | -0.21 | Upgrade |
Free Cash Flow | 2.87 | 1.66 | 2.68 | -0.49 | 1.51 | -0.68 | Upgrade |
Free Cash Flow Per Share | 0.05 | 0.03 | 0.05 | -0.01 | 0.03 | -0.03 | Upgrade |
Gross Margin | 19.25% | 19.03% | 18.60% | 17.27% | 18.17% | 20.40% | Upgrade |
Operating Margin | 2.76% | 1.93% | 0.67% | -2.00% | -3.14% | -1.72% | Upgrade |
Profit Margin | -0.66% | -1.00% | -0.16% | -6.61% | -5.31% | -10.62% | Upgrade |
Free Cash Flow Margin | 3.42% | 2.28% | 4.05% | -0.79% | 2.48% | -1.44% | Upgrade |
EBITDA | 3.35 | 2.43 | 1.62 | -0.17 | -0.26 | 0.6 | Upgrade |
EBITDA Margin | 4.00% | 3.33% | 2.45% | -0.27% | -0.43% | 1.25% | Upgrade |
D&A For EBITDA | 1.04 | 1.02 | 1.18 | 1.08 | 1.65 | 1.42 | Upgrade |
EBIT | 2.32 | 1.41 | 0.44 | -1.26 | -1.91 | -0.82 | Upgrade |
EBIT Margin | 2.76% | 1.93% | 0.67% | -2.00% | -3.14% | -1.72% | Upgrade |
Effective Tax Rate | 245.51% | - | 447.27% | - | - | - | Upgrade |
Revenue as Reported | 83.93 | 72.81 | 66.1 | 62.65 | 60.86 | 47.64 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.